NovoCure ROE 2014-2023 | NVCR
NovoCure ROE - Return on Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Shareholder's Equity | Return on Equity |
2023-12-31 | $-0.21B | $0.36B | -51.37% |
2023-09-30 | $-0.20B | $0.39B | -46.58% |
2023-06-30 | $-0.17B | $0.42B | -40.14% |
2023-03-31 | $-0.14B | $0.43B | -32.05% |
2022-12-31 | $-0.09B | $0.44B | -21.09% |
2022-09-30 | $-0.08B | $0.45B | -18.93% |
2022-06-30 | $-0.07B | $0.44B | -15.99% |
2022-03-31 | $-0.06B | $0.44B | -14.25% |
2021-12-31 | $-0.06B | $0.41B | -14.57% |
2021-09-30 | $-0.03B | $0.41B | -6.51% |
2021-06-30 | $-0.01B | $0.40B | -1.29% |
2021-03-31 | $0.01B | $0.37B | 3.37% |
2020-12-31 | $0.02B | $0.48B | 6.18% |
2020-09-30 | $0.02B | $0.31B | 7.34% |
2020-06-30 | $0.01B | $0.27B | 5.23% |
2020-03-31 | $0.01B | $0.24B | 4.45% |
2019-12-31 | $-0.01B | $0.22B | -4.04% |
2019-09-30 | $-0.03B | $0.19B | -18.40% |
2019-06-30 | $-0.04B | $0.16B | -32.03% |
2019-03-31 | $-0.06B | $0.13B | -48.17% |
2018-12-31 | $-0.07B | $0.11B | -58.43% |
2018-09-30 | $-0.06B | $0.12B | -53.69% |
2018-06-30 | $-0.06B | $0.11B | -52.56% |
2018-03-31 | $-0.06B | $0.11B | -56.26% |
2017-12-31 | $-0.06B | $0.11B | -51.05% |
2017-09-30 | $-0.07B | $0.12B | -56.92% |
2017-06-30 | $-0.10B | $0.12B | -69.47% |
2017-03-31 | $-0.12B | $0.13B | -74.68% |
2016-12-31 | $-0.13B | $0.14B | -74.68% |
2016-09-30 | $-0.14B | $0.16B | -70.10% |
2016-06-30 | $-0.14B | $0.19B | -69.32% |
2015-12-31 | $-0.08B | $0.25B | -63.57% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $1.328B | $0.509B |
NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $124.048B | 15.56 |
Cencora (COR) | United States | $47.467B | 18.94 |
ICON (ICLR) | Ireland | $25.527B | 24.10 |
DiDi Global (DIDIY) | China | $23.901B | 0.00 |
Avantor (AVTR) | United States | $17.269B | 23.79 |
Viatris (VTRS) | United States | $13.856B | 3.96 |
CochLear (CHEOY) | $13.551B | 0.00 | |
Revvity (RVTY) | United States | $12.684B | 22.08 |
Charles River Laboratories (CRL) | United States | $12.333B | 22.48 |
Medpace Holdings (MEDP) | United States | $12.318B | 40.53 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.750B | 0.00 |
Natera (NTRA) | United States | $11.049B | 0.00 |
Solventum (SOLV) | United States | $10.961B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
HealthEquity (HQY) | United States | $6.795B | 50.77 |
Bausch + Lomb (BLCO) | Canada | $5.236B | 20.14 |
Organon (OGN) | United States | $4.783B | 4.63 |
Doximity (DOCS) | United States | $4.461B | 33.21 |
PACS (PACS) | United States | $3.596B | 0.00 |
Surgery Partners (SGRY) | United States | $3.228B | 30.00 |
Sotera Health (SHC) | United States | $3.190B | 15.65 |
Progyny (PGNY) | United States | $3.133B | 52.58 |
Life Times (LTH) | United States | $2.882B | 31.85 |
GoodRx Holdings (GDRX) | United States | $2.749B | 139.20 |
Premier (PINC) | United States | $2.531B | 9.26 |
Teladoc Health (TDOC) | United States | $2.325B | 0.00 |
Agilon Health (AGL) | United States | $2.191B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.167B | 7.01 |
BrightSpring Health Services (BTSG) | United States | $1.845B | 0.00 |
Agiliti (AGTI) | United States | $1.374B | 22.44 |
Establishment Labs Holdings (ESTA) | $1.344B | 0.00 | |
Alignment Healthcare (ALHC) | United States | $0.979B | 0.00 |
Pediatrix Medical (MD) | United States | $0.776B | 8.03 |
Embecta (EMBC) | United States | $0.627B | 4.14 |
Auna S.A (AUNA) | Luxembourg | $0.558B | 0.00 |
InnovAge Holding (INNV) | United States | $0.542B | 0.00 |
Enhabit (EHAB) | United States | $0.510B | 46.23 |
COMPASS Pathways (CMPS) | United Kingdom | $0.502B | 0.00 |
LifeMD (LFMD) | United States | $0.450B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.423B | 0.00 |
CareDx (CDNA) | United States | $0.413B | 0.00 |
Beauty Health (SKIN) | United States | $0.389B | 0.00 |
MultiPlan (MPLN) | United States | $0.375B | 0.00 |
DocGo (DCGO) | United States | $0.367B | 58.67 |
ModivCare (MODV) | United States | $0.353B | 4.68 |
Sera Prognostics (SERA) | United States | $0.326B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.308B | 0.00 |
Sharecare (SHCR) | United States | $0.277B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.265B | 0.00 |
Biodesix (BDSX) | United States | $0.145B | 0.00 |
So-Young (SY) | China | $0.121B | 40.67 |
Oncology Institute (TOI) | United States | $0.089B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.077B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
NeueHealth (NEUE) | United States | $0.053B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
Nutex Health (NUTX) | United States | $0.033B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.028B | 0.00 |
DermTech (DMTK) | United States | $0.021B | 0.00 |
OncoCyte (OCX) | United States | $0.020B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
OpGen (OPGN) | United States | $0.007B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.006B | 0.00 |
Assure Holdings (IONM) | United States | $0.005B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |